The University of Bristol in England has started a randomized trial to investigate why some patients develop infections after their hip or knee replacement surgery, and which type of surgical revision treatment is best. According to Medical Xpress, members of the public are being asked to take part in the trial. “The NIHR-funded INFORM (Infection – Orthopaedic Management) trial compares one-stage with two-stage revision for hip PJI and is co-ordinated by the University’s Musculoskeletal Research Unit, based at Southmead Hospital. The trial’s primary focus is on patient reported outcomes: pain, stiffness, function and wellbeing in the long-term,” according to the article. Full story.